Yeji

$BHVN

Biohaven Ltd.

Runway:7 mo
NYSEMarket cap: —CIK 0001935979

Upcoming catalysts

1 surfaced
AdComDate TBD~ low confidence
$BHVNBiohaven Ltd.
“The Division also informed Biohaven that it is currently planning to hold an advisory committee meeting to discuss the application, but no date has been scheduled.”

Drug pipeline

BHV-0223
Amyotrophic Lateral Sclerosis
Troriluzole
Obsessive-Compulsive Disorder
BHV-2100
Migraine
Riluzole
Amyotrophic Lateral Sclerosis
BHV-1100 plus cytokine induced memory-like (CIML) NK cells plus IVIG and low dose IL-2
Multiple Myeloma
BHV3241, verdiperstat
Multiple System Atrophy (MSA)
BHV-7000
Focal Epilepsy
BHV-1300
Graves Disease
BHV-1400
IgA Nephropathy
BHV-4157
Spinocerebellar Ataxias
BHV-8000
Parkinson Disease
taldefgrobep alfa
Spinal Muscular Atrophy
BHV-1530
Solid Tumor
Verdiperstat
Multiple System Atrophy
BHV-1510
Solid Tumor
Troriluzole (BHV-4157)
Obsessive Compulsive Disorder

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT06874335BHV-1530Phase 1Recruiting2029-03-01
NCT06384807BHV-1510Phase 2Recruiting2028-02-01
NCT06980649BHV-1300Phase 1Recruiting2027-09-01
NCT06976268BHV-8000Phase 3Recruiting2027-08-01
NCT07054684BHV-1400Phase 1Recruiting2027-07-01
NCT06132893BHV-7000Phase 3Recruiting2026-12-01
NCT06443463BHV-7000Phase 2Enrolling By Invitation2026-12-01
NCT07262268BHV-7000Phase 1Enrolling By Invitation2026-11-01
NCT07281495taldefgrobep alfaPhase 2Active Not Recruiting2026-09-01
NCT06309966BHV-7000Phase 3Recruiting2026-05-01
NCT06423781BHV-7000Phase 2Completed2026-03-18
NCT06425159BHV-7000Phase 3Terminated2026-03-12
NCT04708834TroriluzolePhase 3Terminated2026-02-13
NCT06419608BHV-7000Phase 2Completed2025-11-07
NCT04641143TroriluzolePhase 3Completed2025-10-27
NCT04693351TroriluzolePhase 3Completed2025-04-29
NCT06423794BHV-7000Phase 2Terminated2025-04-25
NCT06603623BHV-2100Phase 2Completed2025-03-24
NCT06419582BHV-7000Phase 3Completed2025-01-15
NCT04634435BHV-1100 plus cytokine induced memory-like (CIML) NK cells plus IVIG and low dose IL-2Phase 1Completed2025-01-10

Recent catalysts

AdComAug 21, 2025· 289d ago~ low confidence
$BHVNBiohaven Ltd.
“On August 21, 2025, the Division communicated to the Company that it had determined that an advisory committee meeting is no longer needed for regulatory decision making.”